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Much controversy exists over the fluid composition for hypotensive resuscitation.
Previously we showed that a small volume of 7.5% NaCl/6% Dextran-70
(RescueFlow®) or 7.5% NaCl/hydroxyethyl starch (HES) led to cardiac instability and
mortality (HES). Our aim was to examine the early resuscitative effects of 7.5%
NaCl with adenosine, lidocaine and magnesium (AdenocaineTM) (ALM) on mortality
and hemodynamics in the rat model of severe hemorrhagic shock.
Methods: Male fed Sprague-Dawley rats (300–450g, n=48) were anesthetized and
randomly assigned to one of six groups: 1) Untreated 2) 7.5% saline, 3) 7.5%
NaCl/Mg2+ (M), 4) 7.5% NaCl with adenosine/Mg2+(AM), 5) 7.5% NaCl with
lidocaine/Mg2+ (LM), 6) 7.5% NaCl with ALM. Hemorrhagic shock was induced by
phlebotomy until MAP was 35–40 mmHg and continued for 20 min ( 40% blood
loss). Animals were left in shock for 60 min at 34°C. 0.3 ml (  3.5% of shed blood)
was injected as a 10 sec intravenous (IV) bolus. Lead II ECG, arterial blood
pressures, MAP, heart rate and rate-pressure product (RPP) were monitored.
Results: Untreated rats experienced severe arrhythmias and 38% mortality. There
were no deaths in any treatment group. 7.5% NaCl alone failed to maintain MAP
after 5 min. Interestingly, the presence of Mg2+ had a "colloid-like" effect, and at
60 min the MAP was 48±2 mmHg vs. 36±5 mmHg for the 7.5% NaCl group
(P<0.05). In addition, the Mg2+ group showed a 25% higher RPP than 7.5% NaCl
alone. 7.5% NaCl with ALM led to further increases in MAP and was significantly
higher than all other treatment groups (MAP was 60 mmHg at 60 min; P<0.05).
This higher MAP was associated with a twofold increase in diastolic pressure
compared with 7.5% NaCl alone or AM or LM groups. Both 7.5% NaCl with AM or
LM were mildly bradycardic but not when combined as ALM. A few arrhythmias
occurred in 7.5% NaCl group with or without Mg2+, but no arrhythmias occurred
in the other treatment groups.
Conclusions: 7.5% NaCl with ALM led to a significantly higher MAP (P<0.05),
higher diastolic rescue, higher RPP and a more electrically stable heart compared
with other treatment groups. Ultra-small (<1ml/kg) intravenous bolus of 7.5%
NaCl with ALM may have clinical applications in the early treatment of hemorrhagic
shock on the battlefield or in out-of-hospital environments.
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